Literature DB >> 15398013

The present status of the chemotherapy of tuberculosis with conteben a substance of the thiosemicarbazone series; a review.

A MERTENS, R BUNGE.   

Abstract

Entities:  

Keywords:  CONTEBEN; TUBERCULOSIS

Mesh:

Substances:

Year:  1950        PMID: 15398013     DOI: 10.1164/art.1950.61.1.20

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN: 0096-0381


× No keyword cloud information.
  7 in total

1.  Clinical trial of T.B.3 in surgical tuberculosis.

Authors:  J H MAYER; P G LAING
Journal:  Br Med J       Date:  1953-01-24

2.  The activity of thiosemicarbazones alone and in combination with other drugs in experimental corneal tuberculosis.

Authors:  R J W REES; J M ROBSON
Journal:  Br J Pharmacol Chemother       Date:  1951-03

3.  Some observations on acquired resistance of tubercle bacteria to 4-acetylaminobenzaldehyde thiosemicarbazone.

Authors:  A MANTEN
Journal:  Antonie Van Leeuwenhoek       Date:  1951       Impact factor: 2.271

4.  The treatment of pulmonary tuberculosis with the thiosemicarbazones.

Authors:  S J SHANE; C RILEY; J H LAURIE; M BOUTILIER
Journal:  Can Med Assoc J       Date:  1951-04       Impact factor: 8.262

5.  The toxic and antituberculous effects of two thiosemicarbazones and streptomycin in dogs, monkeys, and guineapigs.

Authors:  J FRANCIS; A SPINKS; G T STEWART
Journal:  Br J Pharmacol Chemother       Date:  1950-12

6.  Intermittent isoniazid and thiacetazone in childhood tuberculosis with reference to clinical intolerance.

Authors:  B Bhandari; A M Jain; S K Kulshrestha; S Mehta
Journal:  Indian J Pediatr       Date:  1972-01       Impact factor: 1.967

7.  A second international co-operative investigation into thioacetazone side-effects. 1. The influence of a vitamin and antihistamine supplement.

Authors:  A B Miller; A J Nunn; D K Robinson; G C Ferguson; W Fox; R Tall
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.